According to a report in the Finnish news site yle Uutiset, researchers believe they have isolated several strains of an enterovirus that they say is responsible for causing Type 1 diabetes. The researchers at Tampere University are confident that, with the proper funding, a vaccine can be developed to inoculate against the virus.
The researchers examined hundreds of strains of a virus they suspected could be responsible for penetrating the pancreas and destroying beta cells, eventually causing Type 1 diabetes. They eventually narrowed their search to 5 strains of the virus, with one eventually identified as the most likely culprit. Next they developed a vaccine to this virus which proved effective in shielding mice from Type 1 diabetes, according to the report.
The next step is to develop a similar vaccine for humans, but here the researchers are up against a significant cost hurdle. A trial of the vaccine would most likely cost 700 million euros, or nearly a billion dollars. Funding is already being raised both in the U.S and Europe for the efforts through the Europe-based Diabetes Prediction and Prevention project (DIPP), but much more will be needed, said lead researcher Heikki Hyöty.
Thanks for reading this Insulin Nation article. Want more Type 1 news? Subscribe here.
Have Type 2 diabetes or know someone who does? Try Type 2 Nation, our sister publication.